Author

Kaiyo Shi

Oregon Health & Science University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Changhui Xue· 1 shared David Z. QianiD· 1 shared Hao Geng· 1 shared Hyun‐Kyung KoiD· 1 shared Janét PittsenbargeriD· 1 shared Kasen Shi· 1 shared Lucien Vu Dao· 1 shared Maximilian Libmann· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Changhui Xue

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Understanding the development of enzalutamide resistance based on a functional single-cell approach

Changhui Xue, Hyun‐Kyung Ko, Kasen Shi, Janét Pittsenbarger, Lucien Vu Dao, Kaiyo Shi, Maximilian Libmann, Hao Geng, David Z. Qian

This study uses single-cell RNA-sequencing to identify a therapy-resistant subpopulation in prostate cancer cells and discovers a potential therapeutic target for enzalutamide resistance.

The Prostate · Apr 10, 2025Peer-reviewedCancer Biology